NCT07164326Not yet recruiting
Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients
Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients Undergoing Caesarean Section Under General Anaesthesia
Source: ClinicalTrials.gov · Last updated 10 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Dexmedetomidine nebulization in sever preeclamptic patients
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 30 Aug 2025
- Start date
- 15 Oct 2025
- Primary completion date
- 15 Nov 2026
- Lead sponsor
- Assiut University
- NCT number
- NCT07164326
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 15 Oct 2025 to the primary completion date, 15 Nov 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery
Other illness
- Cardiac patients
- History of diabetes mellitus
- History to hypersensitivity to the tested drug.
Lab values
- Renal dysfunction (elevated serum creatinine \> 2mg\\dl)
Other
- sever obesity (BMI ≥ 40)
- hepatic dysfunction (elevated hepatic enzyme three times above normal)
- Known fetal anomalies
Who the study is looking for
- Patients with severe pre-eclampsia scheduled for cesarean section under general anesthesia
- ASA II, III
Age in the registry: 18 years to 40 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.